ClearArc Capital’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

ClearArc Capital’s Portfolio COV Stock Details COV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-9,900	Closed	-$1.01M	–	451
2014 Q4	$1.01M	Sell	9,900 -20,692	-68%	-$1.98M	0.21%	140
2014 Q3	$2.65M	Buy	30,592 +3,284	+12%	+$291K	0.6%	37
2014 Q2	$2.46M	Sell	27,308 -14,668	-35%	-$1.1M	0.57%	41
2014 Q1	$3.09M	Sell	41,976 -2,458	-6%	-$171K	0.76%	26
2013 Q4	$3.03M	Sell	44,434 -1,577	-3%	-$103K	0.78%	24
2013 Q3	$2.8M	Sell	46,011 -4,666	-9%	-$285K	0.78%	28
2013 Q2	$2.82M	Buy	+50,677	New	+$2.93M	0.76%	28

ClearArc Capital's COV Position: Q1 2015 in Review

ClearArc Capital sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 9,900 shares — an estimated $1.01M sold.

ClearArc Capital first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $3.09M in Q1 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

ClearArc Capital reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
ClearArc Capital sold 9,900 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $1.01M.
ClearArc Capital first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
ClearArc Capital's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $3.09M in Q1 2014.
1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on ClearArc Capital's 13F filing for Q1 2015, filed 14 May 2015.